Skip to main content
Sign In

An official website of the United States government

U.S. Department of Health & Human Services

Official websites use .gov

A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS

A lock ( ) or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.

State/Territory-Coordinated Distribution of COVID-19 Therapeutics

From September 13, 2021 through April 24, 2022, the HHS Administration for Strategic Preparedness and Response (ASPR) used a state and territory-coordinated distribution system for COVID-19 therapeutics. The tables below are being made available for archival purposes only.

On April 25, HHS/ASPR transitioned to a new system based on established thresholds for each jurisdiction. To find out how HHS/ASPR is currently bringing COVID-19 therapeutics to your state or territory, see COVID-19 Therapeutics Thresholds, Orders, and Replenishment by Jurisdiction.

Total COVID-19 Therapeutics Courses Made Available

September 13, 2021 - April 24, 2022

Distribution Period REGEN-COV Bam/ete Sotrovimab Evusheld Paxlovid Lagevrio (molnupiravir) Bebtelovimab Total Courses Made Available
Total 1,437,824 850,382 929,142 1,048,344 1,739,110 2,699,904 396,080 9,100,786
Current Allocation Frequency Paused Paused Paused Monthly Weekly Weekly Weekly Weekly
Apr 18–Apr 24, 2022 0 0 0 0 175,000 99,960 30,000 304,960
Apr 11–Apr 17, 2022 0 0 0 0 175,000 99,960 30,000 304,960
Apr 4–Apr 10, 2022 0 0 16,608 199,992 175,000 99,984 30,000 521,584
Mar 28–Apr 3, 2022 0 0 29,778 0 175,280 99,960 30,000 335,018
Mar 21–Mar 27, 2022 0 0 33,102 0 175,000 99,984 28,345 336,431
Mar 14–Mar 20, 2022 0 0 52,248 0 175,000 174,960 49,000 451,208
Mar 7–Mar 13, 2022 0 0 52,242 199,992 175,000 174,960 49,000 651,194
Feb 28–Mar 6, 2022 0 0 46,986 49,992 0 0 51,990 148,968
Feb 21-27, 2022 0 0 52,194 49,992 148,980 349,776 49,000 649,942
Feb 14-20, 2022 0 0 52,248 49,992 0 0 48,745 150,985
Feb 7-13, 2022 0 0 52,248 49,264 99,940 399,840 n/a 601,292
Jan 31-Feb 6, 2022 0 0 52,104 74,960 0 0 n/a 127,064
Jan 24-30, 2022 0 0 52,260 74,976 99,980 399,980 n/a 627,196
Jan 17-23, 2022 55,224 44,550 52,064 73,752 0 0 n/a 225,590
Jan 10-16, 2022 55,324 44,880 52,128 74,664 99,960 399,920 n/a 726,876
Jan 3-9, 2022 54,472 44,520 48,498 49,896 0 0 n/a 197,386
Dec 27, 2021 56,454 45,660 49,552 50,664 0 0 n/a 202,330
Dec 23, 2021 0 0 0 0 0 300,620 n/a 300,620
Dec 22, 2021 0 0 0 0 64,970 0 n/a 64,970
Dec 17, 2021 0 0 55,002 0 n/a n/a n/a 55,002
Dec 17, 2021 0 0 0 50,208 n/a n/a n/a 50,208
Dec 13-26, 2021 111,300 88,700 0 0 n/a n/a n/a 200,000
Nov 29-Dec 12, 2021 111,492 90,100 0 n/a n/a n/a n/a 201,592
Nov 15-28, 2021 88,692 52,474 35,166 n/a n/a n/a n/a 176,332
Nov 8-14, 2021 50,004 30,010 20,016 n/a n/a n/a n/a 100,030
Nov 1-7, 2021 63,154 37,740 25,062 n/a n/a n/a n/a 125,956
Oct 25-31, 2021 76,044 45,530 30,330 n/a n/a n/a n/a 151,904
Oct 18-24, 2021 89,208 45,400 27,072 n/a n/a n/a n/a 161,680
Oct 11-17, 2021 64,656 77,010 42,234 n/a n/a n/a n/a 183,900
Oct 4-10, 2021 124,272 66,370 n/a n/a n/a n/a n/a 190,642
Sept 27-Oct 3, 2021 139,644 59,350 n/a n/a n/a n/a n/a 198,994
Sept 21-26, 2021 139,304 60,208 n/a n/a n/a n/a n/a 199,512
Sept 13-20, 2021 158,580 17,880 n/a n/a n/a n/a n/a 176,460

Prior COVID-19 Therapeutic Product Efforts

Date Range Threshold/Distribution/Allocation by Jurisdiction
April 25, 2022 - November 26, 2023 COVID-19 Therapeutics Threshold Determinations
November 9, 2020 - March 2, 2021 Bamlanivimab Distribution
November 24, 2020 - February 2, 2021 REGEN-COV Distribution
July 6, 2020 - October 4, 2020 Allocation of Commercial Veklury (Remdesivir) (PDF)
May 4, 2020 - June 29, 2020 Allocation of Donated Veklury (Remdesivir)

COVID-19 Therapeutics Right-Nav

COVID-19 Therapeutics